News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,751 Results
Type
Article (2717)
Company Profile (7)
Press Release (27027)
Section
Business (8874)
Career Advice (154)
Deals (1369)
Drug Delivery (25)
Drug Development (2595)
Employer Resources (19)
FDA (494)
Job Trends (1044)
News (14206)
Policy (2525)
Tag
Academia (202)
Accelerated approval (2)
Adcomms (1)
Allergies (11)
Alliances (2526)
ALS (5)
Alzheimer's disease (71)
Antibody-drug conjugate (ADC) (41)
Approvals (498)
Artificial intelligence (34)
Autoimmune disease (10)
Automation (4)
Bankruptcy (3)
Best Places to Work (702)
BIOSECURE Act (17)
Biosimilars (32)
Biotechnology (1)
Brain cancer (4)
Breast cancer (37)
Cancer (227)
Cardiovascular disease (11)
Career advice (142)
Career pathing (3)
CAR-T (25)
CDC (13)
Cell therapy (70)
Cervical cancer (2)
Clinical research (1984)
Collaboration (108)
Compensation (16)
Complete response letters (2)
COVID-19 (308)
CRISPR (3)
C-suite (33)
Cystic fibrosis (6)
Data (256)
Depression (3)
Diabetes (27)
Diagnostics (276)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (26)
Drug pricing (60)
Drug shortages (5)
Duchenne muscular dystrophy (5)
Earnings (2312)
Editorial (13)
Employer branding (2)
Employer resources (16)
Events (3636)
Executive appointments (29)
FDA (635)
Frontotemporal dementia (1)
Funding (58)
Gene editing (11)
Generative AI (7)
Gene therapy (39)
GLP-1 (87)
Government (863)
Grass and pollen (5)
Guidances (11)
Healthcare (1436)
HIV (2)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (13)
Immuno-oncology (4)
Indications (8)
Infectious disease (318)
Inflammatory bowel disease (10)
Inflation Reduction Act (4)
Influenza (5)
Intellectual property (10)
Interviews (27)
IPO (555)
IRA (14)
Job creations (356)
Job search strategy (126)
JPM (6)
Labor market (12)
Layoffs (33)
Leadership (4)
Legal (500)
Liver cancer (4)
Lung cancer (40)
Lymphoma (16)
Machine learning (3)
Management (4)
Manufacturing (126)
MASH (1)
Medical device (533)
Medtech (535)
Mergers & acquisitions (877)
Metabolic disorders (80)
Multiple sclerosis (5)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (122)
NextGen: Class of 2026 (573)
Non-profit (567)
Obesity (43)
Opinion (40)
Ovarian cancer (5)
Pain (7)
Pancreatic cancer (7)
Parkinson's disease (9)
Partnered (9)
Patents (14)
Patient recruitment (21)
Peanut (3)
People (2535)
Pharmaceutical (2)
Pharmacy benefit managers (11)
Phase 1 (732)
Phase 2 (836)
Phase 3 (690)
Pipeline (282)
Policy (90)
Postmarket research (52)
Preclinical (327)
Press Release (7)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (17)
Rare diseases (38)
Real estate (1088)
Recruiting (11)
Regulatory (1471)
Reports (3)
Research institute (154)
Resumes & cover letters (15)
Rett syndrome (1)
RNA editing (2)
RSV (4)
Schizophrenia (14)
Series A (13)
Series B (5)
Service/supplier (2)
Special edition (2)
Sponsored (7)
Startups (179)
Stomach cancer (1)
Supply chain (9)
Tariffs (31)
The Weekly (15)
Vaccines (92)
Venture capital (10)
Weight loss (38)
Women's health (4)
Date
Today (5)
Last 7 days (31)
Last 30 days (103)
Last 365 days (1313)
2026 (142)
2025 (1285)
2024 (1554)
2023 (1816)
2022 (2275)
2021 (2636)
2020 (2720)
2019 (3079)
2018 (2332)
2017 (1237)
2016 (1353)
2015 (1453)
2014 (985)
2013 (869)
2012 (944)
2011 (892)
2010 (750)
Location
Africa (62)
Alabama (4)
Alaska (1)
Arizona (9)
Arkansas (2)
Asia (2659)
Australia (235)
California (371)
Canada (108)
China (188)
Colorado (13)
Connecticut (11)
Delaware (6)
Europe (4853)
Florida (41)
Georgia (24)
Idaho (5)
Illinois (45)
India (6)
Indiana (33)
Japan (68)
Kansas (5)
Kentucky (1)
Louisiana (2)
Maine (2)
Maryland (43)
Massachusetts (259)
Michigan (11)
Minnesota (14)
Mississippi (1)
Missouri (5)
Montana (10)
Nevada (4)
New Hampshire (1)
New Jersey (190)
New Mexico (1)
New York (109)
North Carolina (44)
Northern California (170)
Ohio (19)
Oklahoma (2)
Oregon (2)
Pennsylvania (83)
Rhode Island (3)
South America (79)
South Carolina (2)
Southern California (165)
Tennessee (10)
Texas (28)
United States (1384)
Utah (6)
Virginia (8)
Washington D.C. (10)
Washington State (10)
West Virginia (2)
Wisconsin (8)
29,751 Results for "bethany house".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KalVista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors
October 2, 2025
·
4 min read
Regulatory
FDA Frictions Continue as White House Denies Promotion to Makary’s Aide
A source familiar with the matter said the White House initially requested the resignation of Sanjula Jain-Nagpal, a policy and research official at the FDA.
November 24, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee
The House Committee on Energy and Commerce has cleared proposed legislation that could bring back the FDA’s rare pediatric priority review voucher program, which allows for expedited drug reviews.
September 19, 2025
·
2 min read
·
Tristan Manalac
Government
Spending Bill Clears House, Keeping Priority Review Voucher Hopes Alive
The $1.2 trillion budget package will now move to the Senate, which is expected to hold a vote next week.
January 23, 2026
·
3 min read
·
Tristan Manalac
Drug pricing
White House Strikes GLP-1 Pricing Deal With Lilly, Novo
The agreement will also secure a $150 price for future weight loss pills from Novo Nordisk and Eli Lilly—at least initially.
November 6, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
CovarsaDx Appoints Dr. Karen Shannon as In-House Counsel to Support Continued Growth, Compliance and Innovation
November 20, 2025
·
2 min read
Press Releases
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026
December 29, 2025
·
5 min read
Press Releases
Cytovance Biologics Expands Services With In-House Formulation Development
September 3, 2025
·
1 min read
Mergers & acquisitions
Novo CEO Fires Back at Pfizer From White House: ‘Put Your Hand in Your Pocket’
During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ongoing bidding war between Novo Nordisk and Pfizer over obesity biotech Metsera.
November 7, 2025
·
2 min read
·
Annalee Armstrong
Business
Bethany L. Sensenig Joins Supernus’ Board of Directors
Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced that Bethany L. Sensenig has joined the Supernus Board of Directors effective immediately.
August 21, 2023
·
5 min read
1 of 2,976
Next
